"Hours may differ due to Coronavirus response."

During the past decade, Allegheny Valley Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 19 clinical trials were completed, i.e. on average, 70.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 16 clinical trials were completed. i.e. 177.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allegheny Valley Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "SWOG Cancer Research Network" with 9 trials sponsored, "NRG Oncology" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "Bristol-Myers Squibb" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allegheny Valley Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 22 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Biologics, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Allegheny Valley Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Recurrent Breast Carcinoma" (3 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials) and "Stage IIA Lung Non-Small Cell Carcinoma AJCC v7" (3 trials). Many other conditions were trialed in "Allegheny Valley Hospital" in a lesser frequency.

Most popular intervention types in "Allegheny Valley Hospital" are "Drug" (31 trials), "Other" (30 trials), "Biological" (15 trials), "Procedure" (12 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Quality-of-Life Assessment" (13 trials), "Computed Tomography" (7 trials), "Nivolumab" (7 trials) and "Biospecimen Collection" (6 trials). Other intervention names were less common.

The vast majority of trials in "Allegheny Valley Hospital" are 33 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Allegheny Valley Hospital". undefined are not yet recruiting, 11 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Allegheny Valley Hospital, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allegheny Valley Hospital, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".